System and method for ablating breast cancer cells with cold plasma
US11864811B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2019 |
| Grant date | Jan 9, 2024 |
| Priority date | — |
| Expiry date | Jul 8, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2090/378
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method for performing cold atmospheric plasma therapy to treat breast cancer. The cancerous tumor is sampled and cold atmospheric plasma treatment is performed on sampled cancerous tumor cells ex vivo. The results of the testing are stored in an electronic storage media. A cell viability reduction rate of said tested samples is calculated with a processor and stored in memory. An average cell viability reduction rate is then calculated by the processor for the cancerous tumor. Cold atmospheric plasma dosages to be used in treatment of the cancerous tumor in vivo are then projected using the processor. The tumor is surgically removed from the patient. The surgical margins of the tumor are then treated with cold atmospheric plasma at the projected dosages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.